2021 UK Drugs of Abuse Testing Market Assessment for 12 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.
The report is available by section, and can be customized to specific information needs and budget.
This new 260-page report from LeadingMarketResearch.com provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 260 pages and 10 tables
Market and Technology Overview
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
List Of Tables
Major Companies Developing or MarketingDrugs of Abuse Tests
U.K., Drugs of Abuse Test Volume
Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
U.K., Drugs of Abuse Reagent Market
Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
U.K., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
Global Neuromodulation Devices Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2030
The neuromodulation devices market is anticipated to grow at a CAGR of 6.5% over the forecast period of 20202028. According to a study published by Insure Insights on the neuromodulation
USD 3950 View ReportGlobal Neuromarketing Solutions Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
The Global Neuromarketing Solutions market is anticipated to rise at a value CAGR of 9.65% over 20202028. According to a study published by Insure Insights on the Global Neuromarketing Solutions
USD 3950 View Report2024 UK Drugs Abuse Testing Market Assays Supplier Shares
2024 UK Drugs of Abuse Testing Market for 12 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new 260-page
USD 2450 View ReportUK Drugs of Abuse Testing Market
2023 UK Drugs of Abuse Testing Market for 12 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for SuppliersThis unique report from
USD 2500 View ReportFill The Form For Sample Request